Cargando…

Molecular Bases of Diseases Characterized by Hypophosphatemia and Phosphaturia: New Understanding

Serum phosphate levels are regulated in both calcium-dependent and -independent fashions. Active vitamin D increases while PTH decreases serum phosphate levels in association with the elevation of serum calcium. On the other hand, a calcium-independent phosphaturic factor, historically called phosph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozono, Keiichi, Michigami, Toshimi, Namba, Noriyuki, Nakajima, Shigeo, Yamamoto, Takehisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004864/ https://www.ncbi.nlm.nih.gov/pubmed/24790333 http://dx.doi.org/10.1297/cpe.15.129

Ejemplares similares

Osteopetrosis, Hypophosphatemia, and Phosphaturia in a Young Man: A Case Presentation and Differential Diagnosis
por: Mitri, Zahi, et al.
Publicado: (2012)

Roles of Phosphate in Skeleton
por: Michigami, Toshimi, et al.
Publicado: (2019)

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene
por: Miura, Kohji, et al.
Publicado: (2013)

Wnt Signaling in Bone
por: Kubota, Takuo, et al.
Publicado: (2010)

Current concepts in perinatal mineral metabolism
por: Ohata, Yasuhisa, et al.
Publicado: (2016)

Current Understanding on the Molecular Basis of Chondrogenesis
por: Michigami, Toshimi
Publicado: (2014)

Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study
por: Kubota, Takuo, et al.
Publicado: (2020)

A Case of Alternating Oxaluria and Phosphaturia
por: Brasher, C. W. J.
Publicado: (1913)

Stress-Induced Phosphaturia in Weaned Piglets
por: Habich, Malgorzata, et al.
Publicado: (2020)

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial
por: Namba, Noriyuki, et al.
Publicado: (2022)

G-protein Stimulatory α Subunit Is Involved in Osteogenic Activity in Osteoblastic Cell Line SaOS-2 Cells
por: Yamazaki, Miwa, et al.
Publicado: (2006)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

Notes on a Case of Alternating Oxaluria and Phosphaturia
por: Edgeworth, F. H.
Publicado: (1913)

Clinical Practice Guidelines for Hypophosphatasia*
por: Michigami, Toshimi, et al.
Publicado: (2020)

Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X‑linked hypophosphatemia
por: Kamiya, Yasunari, et al.
Publicado: (2022)

An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
por: Miura, Kohji, et al.
Publicado: (2012)

Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss
por: Kubota, Takuo, et al.
Publicado: (2006)

Phosphaturia as a Promising Predictor of Recurrent Stone Formation in Patients with Urolithiasis
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms
por: Santamaría, Rafael, et al.
Publicado: (2018)

Sirolimus Induced Phosphaturia is Not Caused by Inhibition of Renal Apical Sodium Phosphate Cotransporters
por: Haller, Maria, et al.
Publicado: (2012)

A Spectrum of Clinical Presentations in Seven Japanese Patients with Vitamin D Deficiency
por: Kubota, Takuo, et al.
Publicado: (2006)

Skeletal mineralization: mechanisms and diseases
por: Michigami, Toshimi
Publicado: (2019)

Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types
por: Okawa, Rena, et al.
Publicado: (2019)

Clinical Practice Guidelines for Achondroplasia*
por: Kubota, Takuo, et al.
Publicado: (2020)

Multiple Looser zones of osteomalacia in Byler disease with associated vitamin D deficiency, phosphaturia, and elevated FGF23
por: Tarazi, M., et al.
Publicado: (2015)

Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey
por: Fujiwara, Makoto, et al.
Publicado: (2013)

Hepatic phosphate uptake and subsequent nerve-mediated phosphaturia are crucial for phosphate homeostasis following portal vein passage of phosphate in rats
por: Yasuda, Seiichi, et al.
Publicado: (2023)

Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011)

Hypophosphatemia Regulates Molecular Mechanisms of Circadian Rhythm
por: Noguchi, Takashi, et al.
Publicado: (2018)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Endocrinological and phenotype evaluation in a patient with acrodysostosis
por: Ueyama, Kaoru, et al.
Publicado: (2017)

A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa
por: Miura, Kohji, et al.
Publicado: (2011)

Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease
por: Zhang, Shiqin, et al.
Publicado: (2013)

2261. Phosphaturia in HIV-Exposed Uninfected Neonates Associated With Maternal Use of Tenofovir Disoproxil Fumarate in Late Pregnancy
por: Purswani, Murli, et al.
Publicado: (2018)

Clinical Characteristics of Perinatal Lethal Hypophosphatasia: A Report of 6 Cases
por: Nakamura-Utsunomiya, Akari, et al.
Publicado: (2010)

Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease
por: Yasuda, Kie, et al.
Publicado: (2017)

Recent advance in FGF23 – clinical perspectives
por: Michigami, Toshimi
Publicado: (2015)

Roles of osteocytes in phosphate metabolism
por: Michigami, Toshimi
Publicado: (2022)

Paracrine and endocrine functions of osteocytes
por: Michigami, Toshimi
Publicado: (2022)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_teuirtiilefb8kkviqliqfkh17